Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Cibo Huang"'
Publikováno v:
Rheumatology & Autoimmunity, Vol 2, Iss 1, Pp 45-50 (2022)
Abstract Clinical case We report a case of rheumatoid arthritis‐associated peripheral ulcerative keratitis (PUK) successfully treated with tocilizumab. Despite being treated with systemic corticosteroids and several disease‐modifying antirheumati
Externí odkaz:
https://doaj.org/article/81d5af4de50c47e9a4ad4fa6bb5fc864
Autor:
Zhe Chen, Aihua Liu, Yongjing Cheng, Xutao Wang, Xiaomao Xu, Jia Huang, Yuqing Ma, Ming Gao, Cibo Huang
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Since the COVID-19 pandemic, several therapeutic agents have been used in COVID-19 management. However, the results were controversial. Here, we aimed to evaluate the efficacy and safety of hydroxychloroquine (HCQ)/chloroquine (CQ
Externí odkaz:
https://doaj.org/article/8c67a0b5833d435791b062ea47bd0c27
Autor:
Zhaohua Zhu, Qinghong Yu, Xiaomei Leng, Weiyu Han, Zhanguo Li, Cibo Huang, Jieruo Gu, Yi Zhao, Kang Wang, Tianwang Li, Yifang Mei, Jianhua Xu, Zhiyi Zhang, David Hunter, Flavia Cicuttini, Xiaofeng Zeng, Changhai Ding
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Osteoarthritis (OA) is a common chronic disease in older adults. Currently, there are no effective therapies to reduce disease severity and progression of knee OA (KOA), particularly in mid- to late-stages. This study aims to exam
Externí odkaz:
https://doaj.org/article/0fc542fa3cd1426b86d47e77f58a7135
Autor:
Jinmei Su, Mengtao Li, Lan He, Dongbao Zhao, Weiguo Wan, Yi Liu, Jianhua Xu, Jian Xu, Huaxiang Liu, Lindi Jiang, Huaxiang Wu, Xiaoxia Zuo, Cibo Huang, Xiumei Liu, Fen Li, Zhiyi Zhang, Xiangyuan Liu, Lingli Dong, Tianwang Li, Haiying Chen, Jingyang Li, Dongyi He, Xin Lu, Anbin Huang, Yi Tao, Yanyan Wang, Zhuoli Zhang, Wei Wei, Xiaofeng Li, Xiaofeng Zeng
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Objectives: A phase III, 24-weeks Chinese clinical trial demonstrated that efficacy and safety outcomes of treatments with 40 mg/0.8 ml HS016 (n = 416) or adalimumab (n = 232) for active ankylosing spondylitis (AS) patients was comparable. In the pre
Externí odkaz:
https://doaj.org/article/dd75b337108b4686bc8dbcd62ae2a133
Autor:
Yongjing Cheng, Xiaozhen Zhao, Yuling Chen, Yuhui Li, Rulin Jia, Lei Zhu, Cibo Huang, Xiaolin Sun, Haiteng Deng, Zhanguo Li
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199047 (2018)
BACKGROUND:Behcet's disease (BD) is a chronic, multisystem-involved vasculitis and its pathogenesis remains elusive. No specific serological markers for BD diagnosis have been established. Identification of novel diagnostic biomarkers will be helpful
Externí odkaz:
https://doaj.org/article/21dfa74567e84df9b60cadcdb8b92fe0
Autor:
Xu Liu, Jianping Guo, Yuan Jia, Yi Zhao, Xia Liu, Feng Cheng, Xiaoxia Li, Yi Zheng, Xuhua Shi, Haiyun Li, Cibo Huang, Yongjing Cheng, Bei Lai, Yanhong Huang, Tian Wang, Bo Ding, Zhangguo Li
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71373 (2013)
The association between Human Leukocyte Antigen (HLA) class II and rheumatoid arthritis (RA) has been extensively studied, but few reported DR-DQ haplotype. Here we investigated the association of HLA-DRB1, DQA1, DQB1, and DR-DQ haplotypes with RA su
Externí odkaz:
https://doaj.org/article/11096e62267642cf922a1c345abff4ac
Autor:
Di Wu, Jing Li, Dong Xu, Merrill, Joan T., van Vollenhoven, Ronald F., Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiaomei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo
Publikováno v:
Annals of the Rheumatic Diseases; Apr2024, Vol. 83 Issue 4, following p475-487, 22p
Autor:
Xutao Wang, Zhe Chen, Cibo Huang, Xiaomao Xu, Jia Huang, Yongjing Cheng, Ming Gao, Yuqing Ma, Aihua Liu
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Since the COVID-19 pandemic, several therapeutic agents have been used in COVID-19 management. However, the results were controversial. Here, we aimed to evaluate the efficacy and safety of hydroxychloroquine (HCQ)/chloroquine (CQ) in COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24032f908adf78cc853f0c36164ab62e
https://doaj.org/article/8c67a0b5833d435791b062ea47bd0c27
https://doaj.org/article/8c67a0b5833d435791b062ea47bd0c27
Publikováno v:
Rheumatology and Immunology Research. 2:35-42
Objective To enable physicians to understand the efficacy and safety of Tocilizumab (TCZ) in patients with severe coronavirus disease-2019 (COVID-19) Methods We respectively reviewed the clinical records, laboratory results, and chest computed tomogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fffb085701d9efdd2811deb507a473b
https://doi.org/10.2478/rir-2021-0009
https://doi.org/10.2478/rir-2021-0009
Autor:
Xiaofeng Zeng, Qian Wang, Yaolong Chen, Xinping Tian, Weiguo Xiao, Junqiang Lei, Xiaofeng Li, Yan Zhao, Cibo Huang, Huji Xu, Xiaoxia Zuo, L. Sun, Yin Su, Lijun Wu, Mengtao Li, Miaojia Zhang, Zhiyi Zhang, Yi Liu, Dongbao Zhao
Publikováno v:
Rheumatology and Immunology Research. 2:1-14
A multidisciplinary guideline development group was established to formulate this evidence-based diagnosis and treatment guidelines for rheumatoid arthritis (RA) in China. The grading of recommendations, assessment, development, and evaluation (GRADE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f959814d4a92b450f9f54a33c7be20fa
https://doi.org/10.2478/rir-2021-0002
https://doi.org/10.2478/rir-2021-0002